Existing loss of well control event indicators fall short of predicting events in an accurate and timely manner due to a lack ...
Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference ...
OPKO Health is refocusing on drug development, with most pipeline assets in early stages and limited near-term catalysts.
Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
Morning Overview on MSN
Connecticut weighs legalizing plug-in solar panels to cut power bills
Connecticut lawmakers and regulators are weighing whether to legalize plug-in solar panels, small portable devices that ...
Morning Overview on MSN
NASA targets April 1 for Artemis II crewed moon flyby launch
NASA cleared its Artemis II mission for an April 1 launch attempt after completing the Flight Readiness Review, setting the ...
He also stated that there are “hundreds of thousands of people in Tucson who love the Lord and love America." I agree, and ...
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...
March 26, 2026) - PetroTal Corp. (TSX: TAL) (AIM: PTAL) (OTCQX: PTALF) ("PetroTal" or the "Company") is pleased to report it ...
PetroTal Corp. (TSX: TAL) (AIM: PTAL) (OTCQX: PTALF) ("PetroTal" or the "Company") is pleased to report its operating and financial ...
The FDA has approved a higher dose version of the GLP-1 drug Wegovy, which could lead to greater weight loss. The new dose is ...
Ashley is a lead editor of mortgages and loans at Forbes Advisor. She graduated from Utah Tech University with a bachelor’s in English with an emphasis in creative writing. She began her career ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results